Continuous advancements in immunoassay technologies are improving ELISA testing capabilities. Manufacturers are focusing on enhancing assay sensitivity, specificity, and reproducibility to meet evolving laboratory requirements. Market Overview The Enzyme-Linked Immunosorbent Assay (ELISA) Market was valued at US$ 2.47 billion in 2025 and is projected to reach US$ 4.13 billion by 2034,...